Literature DB >> 22066042

The indices of body size and aggressiveness of papillary thyroid carcinoma.

Ju-Yeon Kim1, Eun-Jung Jung, Sang-Ho Jeong, Chi-Young Jeong, Young-Tae Ju, Young-Jun Lee, Soon-Chan Hong, Sang-Kyeong Choi, Woo-Song Ha, Soon-Tae Park.   

Abstract

PURPOSE: The incidence of papillary thyroid carcinoma (PTC) is increasing worldwide. Positive associations between indices of body size and thyroid cancer have been reported. However, the relationships to cancer severities and/or behaviors are uncertain.
METHODS: We performed a retrospective analysis of the data of patients who underwent total thyroidectomy due to PTC. The epidemiologic factor and pathologic report after operation were determined based on chart review. The relationships between indices of body size and these parameters were assessed.
RESULTS: Positive association between body mass index and T stage was found, but it was not statically significant. In neck lymph node metastasis, the group with metastasis had a tendency for larger mean height and weight, but significant difference was found only in height. However, in the multivariate analysis, the age and size of nodules were only identified as independent risk factors of neck lymph node metastasis (P = 0.000 and 0.019).
CONCLUSION: There was no independent association between indices of body size and stages of PTC in patients who underwent total thyroidectomy.

Entities:  

Keywords:  Body mass index; Body size; Height; Papillary thyroid carcinoma; Weight

Year:  2011        PMID: 22066042      PMCID: PMC3204682          DOI: 10.4174/jkss.2011.80.4.241

Source DB:  PubMed          Journal:  J Korean Surg Soc        ISSN: 1226-0053


  16 in total

1.  A pooled analysis of thyroid cancer studies. V. Anthropometric factors.

Authors:  L Dal Maso; C La Vecchia; S Franceschi; S Preston-Martin; E Ron; F Levi; W Mack; S D Mark; A McTiernan; L Kolonel; K Mabuchi; F Jin; G Wingren; M R Galanti; A Hallquist; E Glattre; E Lund; D Linos; E Negri
Journal:  Cancer Causes Control       Date:  2000-02       Impact factor: 2.506

2.  Increasing incidence of thyroid cancer in the United States, 1973-2002.

Authors:  Louise Davies; H Gilbert Welch
Journal:  JAMA       Date:  2006-05-10       Impact factor: 56.272

3.  The relationship between body mass index and thyroid cancer pathology features and outcomes: a clinicopathological cohort study.

Authors:  John E Paes; Keding Hua; Rebecca Nagy; Richard T Kloos; David Jarjoura; Matthew D Ringel
Journal:  J Clin Endocrinol Metab       Date:  2010-06-02       Impact factor: 5.958

4.  Lifestyle and other risk factors for thyroid cancer in Los Angeles County females.

Authors:  Wendy J Mack; Susan Preston-Martin; Leslie Bernstein; Dajun Qian
Journal:  Ann Epidemiol       Date:  2002-08       Impact factor: 3.797

5.  A population-based case-control study of thyroid cancer.

Authors:  E Ron; R A Kleinerman; J D Boice; V A LiVolsi; J T Flannery; J F Fraumeni
Journal:  J Natl Cancer Inst       Date:  1987-07       Impact factor: 13.506

6.  Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.

Authors:  K C Loh; F S Greenspan; L Gee; T R Miller; P P Yeo
Journal:  J Clin Endocrinol Metab       Date:  1997-11       Impact factor: 5.958

7.  Height and site-specific cancer risk: A cohort study of a korean adult population.

Authors:  Joohon Sung; Yun-Mi Song; Debbie A Lawlor; George Davey Smith; Shah Ebrahim
Journal:  Am J Epidemiol       Date:  2009-04-29       Impact factor: 4.897

8.  Prospective study of body mass index, physical activity and thyroid cancer.

Authors:  Michael F Leitzmann; Alina Brenner; Steven C Moore; Corinna Koebnick; Yikyung Park; Albert Hollenbeck; Arthur Schatzkin; Elaine Ron
Journal:  Int J Cancer       Date:  2010-06-15       Impact factor: 7.396

9.  Body size and thyroid cancer in two million Norwegian men and women.

Authors:  A Engeland; S Tretli; L A Akslen; T Bjørge
Journal:  Br J Cancer       Date:  2006-07-11       Impact factor: 7.640

10.  The association of body size, reproductive factors and thyroid cancer.

Authors:  M T Goodman; L N Kolonel; L R Wilkens
Journal:  Br J Cancer       Date:  1992-12       Impact factor: 7.640

View more
  11 in total

1.  Is body mass index relevant to prognosis of papillary thyroid carcinoma? A clinicopathological cohort study.

Authors:  Yoo Seung Chung; Joon-Hyop Lee; Young Don Lee
Journal:  Surg Today       Date:  2016-09-21       Impact factor: 2.549

2.  Associations between body mass and papillary thyroid cancer stage and tumor size: a population-based study.

Authors:  Peter Dieringer; Evan M Klass; Brenna Caine; Julie Smith-Gagen
Journal:  J Cancer Res Clin Oncol       Date:  2014-08-12       Impact factor: 4.553

3.  A meta-analysis of the influence of body mass index on the clinicopathologic progression of papillary thyroid carcinoma.

Authors:  Ningning Cui; Qian Sun; Li Chen
Journal:  Medicine (Baltimore)       Date:  2021-08-13       Impact factor: 1.817

4.  Correlation between obesity and clinicopathological factors in patients with papillary thyroid cancer.

Authors:  Shin-Hyuk Kim; Hyung Seok Park; Ki-Ho Kim; Ho Yoo; Byung-Joo Chae; Ja-Seong Bae; Sang-Seol Jung; Byung-Joo Song
Journal:  Surg Today       Date:  2014-07-25       Impact factor: 2.549

5.  A missense polymorphism (rs11895564, Ala380Thr) of integrin alpha 6 is associated with the development and progression of papillary thyroid carcinoma in Korean population.

Authors:  Su Kang Kim; Dong Kwan Kim; In-Hwan Oh; Jeong Yoon Song; Kee Hwan Kwon; Bong-Keun Choe; Yong Ho Kim
Journal:  J Korean Surg Soc       Date:  2011-11-01

6.  Lack of Associations between Body Mass Index and Clinical Outcomes in Patients with Papillary Thyroid Carcinoma.

Authors:  Hyemi Kwon; Mijin Kim; Yun Mi Choi; Eun Kyung Jang; Min Ji Jeon; Won Gu Kim; Tae Yong Kim; Young Kee Shong; Dong Eun Song; Jung Hwan Baek; Suck Joon Hong; Won Bae Kim
Journal:  Endocrinol Metab (Seoul)       Date:  2014-11-26

7.  Pretreatment BMI Is Associated with Aggressive Clinicopathological Features of Papillary Thyroid Carcinoma: A Multicenter Study.

Authors:  Shi-Tong Yu; Wanzhi Chen; Qian Cai; Faya Liang; Debin Xu; Ping Han; Jichun Yu; Xiaoming Huang
Journal:  Int J Endocrinol       Date:  2017-09-20       Impact factor: 3.257

8.  Interplay between Body Size Measures and Thyroid Cancer Aggressiveness: A Retrospective Analysis.

Authors:  Thaís Gomes de Melo; Ligia Vera Montali da Assumpção; Denise Engelbrecht Zantut-Wittmann
Journal:  Int J Endocrinol       Date:  2018-08-27       Impact factor: 3.257

9.  The impact of BMI on clinical progress, response to treatment, and disease course in patients with differentiated thyroid cancer.

Authors:  Danuta Gąsior-Perczak; Iwona Pałyga; Monika Szymonek; Artur Kowalik; Agnieszka Walczyk; Janusz Kopczyński; Katarzyna Lizis-Kolus; Tomasz Trybek; Estera Mikina; Dorota Szyska-Skrobot; Klaudia Gadawska-Juszczyk; Stefan Hurej; Artur Szczodry; Anna Słuszniak; Janusz Słuszniak; Ryszard Mężyk; Stanisław Góźdź; Aldona Kowalska
Journal:  PLoS One       Date:  2018-10-01       Impact factor: 3.240

10.  Association Between Aggressive Clinicopathologic Features of Papillary Thyroid Carcinoma and Body Mass Index: A Systematic Review and Meta-Analysis.

Authors:  Aliki Economides; Konstantinos Giannakou; Ioannis Mamais; Panayiotis A Economides; Panagiotis Papageorgis
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-30       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.